Veenat 400mg is an advanced pharmaceutical formulation designed specifically for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). As a targeted therapy utilizing the active ingredient Imatinib, Veenat 400mg works effectively to inhibit the growth of abnormal cancer cells. This medication is essential for oncologists who prescribe it to enhance patient outcomes in the fight against these types of cancer. Administered in the form of tablets, Veenat 400mg offers an oral solution that provides flexibility and ease of use for patients. Patients should be aware that like all medications, Veenat has potential side effects, and consultation with a healthcare provider is critical. Supported by Parshva Agency, known for its quality manufacturing practices, regulatory compliance, and customer-centric solutions, Veenat ensures that patients receive a reliable therapeutic option that meets stringent industry standards. Patients and healthcare providers alike can trust in the efficacy of Veenat 400mg, confident in its WHO-GMP certification and commitment to safety.
Key Features
| Features | Description |
|---|---|
| Formulation | Veenat 400mg is an oral tablet containing Imatinib. |
| Indications | Effective for treating chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). |
| Mechanism of Action | Targeted therapy inhibiting abnormal cell growth. |
| Manufacturing Quality | Manufactured under WHO-GMP certified facilities. |
| Consultation Requirement | Healthcare provider consultation recommended prior to use. |
| Attributes | Description |
|---|---|
| Generic Name | Rituximab |
| Strength | 400mg per tablet |
| Package Type | Blister pack |
| Dosage Form | Oral tablet |
| Side Effects | Potential side effects exist; consult medical provider. |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Veenat 400mg is specifically used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Patients should understand that Veenat 400mg can have potential side effects, and it is essential to consult a healthcare provider for personalized advice and management.
Veenat 400mg is administered orally in the form of tablets.
Yes, Veenat 400mg is manufactured in facilities that meet WHO-GMP certification, ensuring quality and safety.
Parshva Agency offers customer-centric solutions, regulatory support, and a commitment to quality and compliance through state-of-the-art manufacturing.
Brand: parshva agency
Country Of Origin: India
Generic Name:?Rituximab
Dosage:?Veenat 100mg Tablets?/?Veenat 400mg Tablets
Imatinib Tablets are a vital medication used in cancer treatment.
Veenat tablets are prescribed by oncologists to combat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
They work as targeted therapy, effectively inhibiting abnormal cell growth. Administered orally, Imatinib Tablets can have potential side effects, so it's essential to consult a healthcare provider for guidance when using them.
Inclusive of all taxes
You Save: 0
Mumbai , India
Service Provider , Professional Services, Contractor, Retailer, Trader, Distributor, Exporter, Merchant
